Intramuscular Matrix-M-adjuvanted virosomal H5N1 vaccine induces high frequencies of multifunctional Th1 CD4+ cells and strong antibody responses in mice
- 9 December 2009
- journal article
- research article
- Published by Elsevier BV in Vaccine
- Vol. 27 (52), 7367-7376
- https://doi.org/10.1016/j.vaccine.2009.09.044
Abstract
No abstract availableThis publication has 55 references indexed in Scilit:
- A phase I clinical trial of a PER.C6® cell grown influenza H7 virus vaccineVaccine, 2009
- Immunogenicity and Protective Efficacy of Prime-Boost Regimens with Recombinant Δ ureC hly + Mycobacterium bovis BCG and Modified Vaccinia Virus Ankara Expressing M. tuberculosis Antigen 85A against Murine TuberculosisInfection and Immunity, 2009
- Polyfunctional T cell responses are a hallmark of HIV‐2 infectionEuropean Journal of Immunology, 2008
- Cross-Protection against Lethal H5N1 Challenge in Ferrets with an Adjuvanted Pandemic Influenza VaccinePLOS ONE, 2008
- Quality and Kinetics of the Antibody Response in Mice after Three Different Low-Dose Influenza Virus Vaccination StrategiesClinical and Vaccine Immunology, 2007
- Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania majorNature Medicine, 2007
- Live, Attenuated Influenza A H5N1 Candidate Vaccines Provide Broad Cross-Protection in Mice and FerretsPLoS Medicine, 2006
- Detection of anti-H5 responses in human sera by HI using horse erythrocytes following MF59-adjuvanted influenza A/Duck/Singapore/97 vaccineVirus Research, 2004
- Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenzaThe Lancet, 2001
- The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B virusesEpidemiology and Infection, 1972